abrdn Asia Limited reduces stake in Vijaya Diagnostic Centre

1 min read     Updated on 01 Jul 2026, 11:51 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

abrdn Asia Limited reduced its stake in Vijaya Diagnostic Centre Limited by selling 133,199 shares on June 29, 2026. The open market sale lowered the acquirer's holding to 3.2373%, or 3,331,046 shares. The transaction was disclosed under SEBI takeover regulations.

powered bylight_fuzz_icon
44432468

*this image is generated using AI for illustrative purposes only.

abrdn Asia Limited, acting on behalf of funds advised and managed by the group, reduced its shareholding in Vijaya Diagnostic Centre Limited through an open market sale on June 29, 2026. The transaction involved the disposal of 133,199 equity shares, resulting in a decrease of the acquirer's voting rights by 0.1294%. This regulatory filing was submitted under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Prior to the sale, the acquirer held 3,464,245 shares, representing 3.3667% of the total share capital. The shares were held across various funds within the Aberdeen Group, including the Aberdeen Group plc Segregated Fund, Aberdeen India Fund, Inc., and Aberdeen Asia Focus plc. Registered holders for these securities included entities such as Pictet & Cie - Switzerland, State Street Bank & Trust, and BNP Paribas Securities Services.

The disposal was executed entirely through the open market mode. As a result of the transaction, the total holding of abrdn Asia Limited and its Persons Acting in Concert (PAC) now stands at 3,331,046 shares. This revised holding constitutes 3.2373% of the total voting capital of Vijaya Diagnostic Centre Limited. The equity share capital of the company remains unchanged at Rs. 102,896,728, based on a par value of Rs 1.

The filing confirms that the acquirer does not belong to the promoter or promoter group of the target company. The shares of Vijaya Diagnostic Centre Limited are listed on BSE Limited and the National Stock Exchange of India Ltd. The disclosure was signed by Jenny Clarke, an authorised signatory for abrdn Asia Limited, in Edinburgh on June 30, 2026.

Shareholding Details

The following table outlines the changes in the acquirer's shareholding:

Description Number of Shares % of Total Share Capital % of Diluted Share Capital
Holding Before Sale
Shares carrying voting rights 3,464,245 3.3667 3.3667
Transaction Details
Shares sold -133,199 -0.1294 -0.1294
Holding After Sale
Shares carrying voting rights 3,331,046 3.2373 3.2373

Historical Stock Returns for Vijaya Diagnostic Centre

1 Day5 Days1 Month6 Months1 Year5 Years
-2.33%-0.19%+3.66%+28.89%+39.33%+120.16%

Does this sale signal a broader shift in abrdn’s investment strategy regarding the Indian healthcare sector?

How might this reduction in institutional holding impact the liquidity and trading volume of Vijaya Diagnostic Centre shares?

Is abrdn planning to further decrease its stake in the company in the upcoming quarters?

Vijaya Diagnostic Centre
View Company Insights
View All News
like15
dislike

Vijaya Diagnostic Centre Records ₹57.09 Crore Block Trade on NSE at ₹1349.50 Per Share

0 min read     Updated on 30 Jun 2026, 12:56 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Vijaya Diagnostic Centre recorded a significant block trade on the NSE, with approximately 423,055 shares changing hands at ₹1349.50 per share, amounting to a total deal value of ₹57.09 crores. Such block trades are typically executed by large institutional investors or high-net-worth individuals and are closely monitored by market participants for insights into large investor activity.

powered bylight_fuzz_icon
44254113

*this image is generated using AI for illustrative purposes only.

Vijaya Diagnostic Centre witnessed a notable block trade on the National Stock Exchange (NSE), with approximately 423,055 shares transacted at a price of ₹1349.50 per share. The total value of the block deal stood at ₹57.09 crores, indicating significant large-lot trading activity in the stock.

Block Trade Details

The following table summarizes the key parameters of the block trade recorded on the NSE:

Parameter: Details
Exchange: NSE
Number of Shares: ~423,055
Trade Price: ₹1349.50 per share
Total Trade Value: ₹57.09 crores

Block trades of this nature typically involve large institutional investors or high-net-worth individuals executing bulk transactions outside the regular market order book. Such trades are reported separately on the exchange's block deal window and are closely tracked by market participants for insights into large investor activity.

Historical Stock Returns for Vijaya Diagnostic Centre

1 Day5 Days1 Month6 Months1 Year5 Years
-2.33%-0.19%+3.66%+28.89%+39.33%+120.16%

What impact will this block trade have on Vijaya Diagnostic Centre's stock price in the upcoming trading sessions?

Who are the potential buyers or sellers involved in this transaction, and what does it indicate about their outlook on the stock?

Could this block trade signal a broader trend of institutional interest or exit in the healthcare diagnostics sector?

Vijaya Diagnostic Centre
View Company Insights
View All News
like20
dislike

More News on Vijaya Diagnostic Centre

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+39.33%